HLD-0915 has received FDA fast track designation for mCRPC, expediting its development and review process to address unmet medical needs. Halda Therapeutics is conducting a phase 1/2 clinical trial to ...
Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
A new procedure at North Colorado Medical Center in Greeley is helping men with a common medical issue as they age. While stress incontinence is a common issue in women‚ leading to urinary leakage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results